Literature DB >> 6895017

Cardiac biopsy of Kawasaki disease.

C Yutani, S Go, T Kamiya, O Hirose, H Misawa, H Maeda, T Kozuka, S Onishi.   

Abstract

Two hundred one patients (138 boys, 63 girls), 1 month to 11 years old, with Kawasaki disease underwent coronary angiography, ultrasonic tomography, myocardial imaging, and biopsy of right ventricular myocardium. Aneurysms of epicardial coronary arteries, mostly left, occurred in 26 cases (12.9%). Degeneration and proliferation of endothelium, edema, scarring, and fibrosis, slight to moderate, involved the tunicae of intramural small vessels in all cases. These changes tended to abate with time. The basic lesion of Kawasaki disease, round-cell myocarditis and fibrosis, involved all cases and persisted. Disarrangement, abnormal branching, disarray, and hypertrophy of myocytes correlated significantly with myocarditis, but not with epimural or intramural coronary angitis. As a consequence of the myocardial changes, it is suggested that some cases may terminate as myocardiopathy. Scoring criteria for vascular and myocardial changes in biopsy specimens are included.

Entities:  

Mesh:

Year:  1981        PMID: 6895017

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  45 in total

1.  [Kawasaki disease in children and adolescents].

Authors:  U Neudorf
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

2.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

3.  Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Daniel Phadke; Sonali S Patel; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glode; Pei-Ni Jone
Journal:  Pediatr Cardiol       Date:  2015-05-21       Impact factor: 1.655

4.  Active versus borderline myocarditis: clinicopathological correlates and prognostic implications.

Authors:  A Angelini; M Crosato; G M Boffa; F Calabrese; V Calzolari; R Chioin; L Daliento; G Thiene
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Chia-Hung Kao; Betau Hwang; Sheng-Ling Jan; Ching-Shiang Chi
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

6.  Late symptomatic myocarditis in Kawasaki disease: an unusual manifestation.

Authors:  Madhusudan S; Surjit Singh; Manojkumar Rohit; Anju Gupta; Deepti Suri; Amit Rawat
Journal:  Indian J Pediatr       Date:  2014-02-05       Impact factor: 1.967

7.  Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease.

Authors:  Hugo Gravel; Nagib Dahdah; Anne Fournier; Marie-Ève Mathieu; Daniel Curnier
Journal:  Pediatr Cardiol       Date:  2012-02-18       Impact factor: 1.655

8.  QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities.

Authors:  Sunil J Ghelani; Surjit Singh; Rohit Manojkumar
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

Review 9.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

10.  Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

Authors:  M Fukazawa; J Fukushige; T Takeuchi; H Narabayashi; H Igarashi; T Hijii; K Ueda; Y Kuwabara; M Otsuka; Y Ichiya
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.